Vetoquinol risk profile

42 Elevated one input has moved against it

Measured 21 October 2026 from VETO's filed statements. Recomputed nightly.

42 (Elevated), driven by Competitive position at 58, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation37NormalStableOne-year price volatility — 30.5%
Operating pressure40ElevatedEasingCosts outgrowing revenue — -0.9 percentage points
Cash conversion33NormalWorseningCash conversion — 1.26x
Leverage and coverage4ContainedStableCurrent ratio — 3.08x
Competitive position58ElevatedStableRevenue-growth gap against peers — -34.4 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Vetoquinol